Lunglife Ai Share Discussion Threads

[luckyabbeygale] 02/1/2024 09:17

I always buy in the just Incase it does do a big rise. I would hate to miss out.

[firestarter1] 02/1/2024 09:04

Really donkeynkan

[brummy_git] 02/1/2024 08:25

LungLife's patented Circulating Tumour Cell blood test (LungLB) successfully passes its pivotal 425 person, 17 site, validation study (commenced Feb’22) with flying colours.

All the details here.

[luckyabbeygale] 02/1/2024 08:08

A min rise of 200 percent is expected today.

[adorling] 02/1/2024 07:41

Transformational RNS - yes! Going to be a multi-bag opportunity with commercial strategy to commence Q1 2024.

[babbler] 02/1/2024 07:37

Excellent...and leaky ship ot seems

[adorling] 29/12/2023 08:23

About time Management put out an RNS to say they expect to release trial results soon to stop this relentless decline. The only positive is when they do publish them the illiquidity will drive the price up very steeply as people scramble to get back in having sold out previously. It went from just over 22p to 120p last time so I would settle for a 6-bag on good news!

[adorling] 29/12/2023 08:22

What chance of news in the next few weeks?

[hatfullofsky] 29/12/2023 01:02

Brutal fall, selling is relentless. Need those (positive) results

[hatfullofsky] 21/12/2023 06:58

They would release the results (which I expect to mirror the earlier study results) before any raise as that would generate lots more interest. Price may spike but it would be a discounted placing on the spiked price, probably around these levels.I do agree that it is an illiquid stock, which is only available on certain platforms.

[donk7] 20/12/2023 17:23

Birmingham, has your pal Justin been knocking these out recently? Justin is an impressive small-cap stock picker but incredibly opaque regarding his buys, sells and trading intentions. I'm not sure that is the right way for someone who promotes his often illiquid stocks so forcefully. You can't get much more illiquid than LLAI.

The issue with LungLife is that they will need to raise funds. That's no secret. It's not an easy market to do that and I'd assume those willing to fund will only want to come in before results rather than after a potential decent rise post positive results.

No guarantees the results will be good but I'd imagine they would be decent. So my guess is a placing followed by results. I don't hold as it is too illiquid but it's one to watch. If they do a placing then hopefully that will make it less liquid.

[adorling] 20/12/2023 16:28

It could still catch everyone out who sold today. Let’s see?

[deanmatlazin] 20/12/2023 15:51

bad news is coming i guess.

[parsons4] 19/12/2023 07:53

Still waiting !!!! I have reduced my holding just in case of bad news as this is going to the line !!

[hatfullofsky] 16/12/2023 08:22

Somebody has been selling down, small sells throughout December

[deanmatlazin] 24/10/2023 12:01

I am eagerly waiting for the result to come out. Positive result, with potential revenue between $3billions to $6 billions and the share also traded in US, another 10 bagger in the making

[joseph moran] 20/10/2023 13:56

My Buy At
£0.734
is showing as a sell.

[brummy_git] 28/9/2023 09:09

LungLife shares have been unfairly sold off today - after administrative issues have delayed the release of it's pivotal validation study results.

All the details here.

[theclangers] 26/9/2023 13:57

how do you go about buying shares in this company, the only option that seems available to me, is to use a market order, basically it means, buy at the best available price, so how can the MM be trusted to sell me some, that's not above the offer price? So If I want in, do I have to trust the MM not to rip me off?

[softmallow] 22/8/2023 08:22

BVX similar potential for big rise according to some.

[hatfullofsky] 21/8/2023 18:02

Justin Waite is pumping LLAIhttps://youtu.be/d2PKcUV_azA

[idomeneo] 21/8/2023 11:39

There are a minimum of ~300K biopsies of indeterminate nodules (i.e. 1.5m nodules * 20%).

If they can get just 5% of the market then they would be selling 300k * 0.1 * $2000 = $300m tests a year.